- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Value of Medicines
- Research
- About
The Catalyst
Tips for Navigating Medicare Part D Open Enrollment
![](https://webarchive.library.unt.edu/web/20121016195533im_/http://catalyst.phrma.org/assets/Part-D-Snip-147x113.jpg)
10/16/2012 11:00 AM
By Jenni Brewer
Yesterday kicked off the 2013 Medicare Part D open enrollment period, during which millions of Medicare-eligible Americans over 65 and persons with disabilities can choose a new Part D plan that best fits their needs. As Medicare Today recently highlighted in a survey, 90 percent of seniors are satisfied with their Part D plan, with [...]
National Alliance on Mental Illness Guest Post: Development of New Medications to Treat Serious Mental Illness
![](https://webarchive.library.unt.edu/web/20121016195533im_/http://catalyst.phrma.org/assets/Michael-Fitzpatrick-147x113.jpg)
10/10/2012 09:00 AM
By Preet Bilinski
Michael J. Fitzpatrick is executive director at NAMI, the National Alliance on Mental Illness. Prior to taking that role in January of 2004, he served both as the director of NAMI’s Policy Research Institute and as NAMI’s national director of policy. Since 1990, when Congress established the first full week of October as Mental Illness [...]
Changing Attitudes when it comes to Mental Illness
![](https://webarchive.library.unt.edu/web/20121016195533im_/http://catalyst.phrma.org/assets/mental-illness-147x113.png)
10/09/2012 12:02 PM
By Preet Bilinski
The stigma that surrounds mental illness remains a challenge. It can be difficult even for patients to accept and understand their diagnosis. So this week we join others in the mental health community participating in Mental Illness Awareness Week. Mental illness places a heavy burden on patients. The stress associated with coming to terms with [...]
The Spotlight
#STEM and Scientific Literacy Panel feat. Frank Douglas, President/CEO of @ABIAkron and @RepDonnaEdwards! #MedInnovate t.co/hQyRluB6
September 13 at 3:14pm
Subscribe to our Email Updates
Facebook/Twitter Lists
But 100% is better! Medicare open enrollment starts Monday, Oct. 15 and runs through Dec. 7. You can make a difference by sharing this info and helping your loved one find the right plan at https://www.medicare.gov/find-a-plan/questions/home.aspx
likes: 52 | comments: 6
Since 2000, PhRMA member companies invested $500 billion in research and development. See how this $500 billion investment compares to other major purchases. Like - if you agree that life saving medicines are more important than iPhones or NFL Stadiums.
likes: 88 | comments: 5
Medicare Today released its 2012 beneficiary satisfaction survey results today. To put it simply, seniors love Medicare Part D. Satisfaction rates have increased from 78% to 90% since Part D’s implementation in 2006, but that’s not all. Read more about the noteworthy survey results on The Catal...
likes: 327 | comments: 2
#Innovation key to getting US economy moving again says #PhRMA Chair & @Lillypad CEO http://t.co/qkUhVzvI
10.11.2012 // Retweets: 5
#PartD enrollment begins next week & @avalerehealth found more plans have premiums less than $20 #WhyPartDWorks http://t.co/gGhH5SSR
10.12.2012 // Retweets: 3
America can lose its global edge in #medicine unless we do more to promote/reward #innovation in the US. More here:http://t.co/4nZaDn22
07.18.2012 // Retweets: 3
Watch #PhRMA CEO John Castellani's National Press Club speech on archive feed at http://t.co/sj0MiVvP #FromHopeToCures
09.20.2012 // Retweets: 3
Helpful resources from #PhRMA CEO Press Club speech today: speech http://t.co/0ka9tfiT Related blog post: http://t.co/mQAxoYSt
09.20.2012 // Retweets: 3